Probionova relies on its leading scientific standing in the research and development of new probiotics in unprecedented or nearly unexplored fields, by investigating their therapeutic potential.
We strongly believe that biology will be the next great revolution in the pharmaceutical sector, further moving new drug R&D away from chemical-synthesis APIs to biological therapeutic agents.
Research on human microbiome proved that our health and sickness conditions are closely linked to our gut microbes. As a consequence, Probionova decided to make large investments in the probiotic sector, firmly believing in their active contribution to the development of new-generation medications.
